Generation Bio Co.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jason P Rhodes. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jason P Rhodes har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Director 1.958.427
US:REPL / Replimune Group, Inc. Director 16.500
US:GMTX / Gemini Therapeutics Inc Director, 10% Owner 17.245
US:GBIO / Generation Bio Co. Director 608
US:EPZM / Epizyme Inc President, CFO and Treasurer 149.459
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jason P Rhodes. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb GBIO / Generation Bio Co. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GBIO / Generation Bio Co.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GBIO / Generation Bio Co. Insider Trades
Insidersalg GBIO / Generation Bio Co. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GBIO / Generation Bio Co.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GBIO / Generation Bio Co. Insider Trades
Insiderkøb REPL / Replimune Group, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GBIO / Generation Bio Co.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-11-18 REPL Rhodes Jason P 1.100.000 13,6100 1.100.000 13,6100 14.971.000 365 48.9100 38.830.000 259,37

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

REPL / Replimune Group, Inc. Insider Trades
Insidersalg REPL / Replimune Group, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GBIO / Generation Bio Co.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

REPL / Replimune Group, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jason P Rhodes som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-01-29 2025-01-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
A - Award 1.111.111 1.958.427 131,13 13,50 14.999.998 26.438.764
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -72 847.316 -0,01 33,10 -2.383 28.046.160
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -123 1.458.568 -0,01 33,10 -4.071 48.278.601
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -4 15.962 -0,03 33,10 -132 528.342
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -583 5.697.508 -0,01 33,10 -19.297 188.587.515
2024-03-05 2024-03-01 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -17.099 847.388 -1,98 30,05 -513.825 25.464.009
2024-03-05 2024-03-01 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -29.435 1.458.691 -1,98 30,05 -884.522 43.833.665
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -210 864.487 -0,02 25,25 -5.302 21.828.297
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -13.109 864.697 -1,49 24,83 -325.496 21.470.427
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -360 1.488.126 -0,02 25,25 -9.090 37.575.182
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -22.567 1.488.486 -1,49 24,83 -560.339 36.959.107
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.430 5.698.091 -0,04 25,25 -61.358 143.876.798
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -152.244 5.700.521 -2,60 24,83 -3.780.219 141.543.936
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.216 877.806 -0,25 24,68 -54.691 21.664.252
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -23.505 880.022 -2,60 24,38 -573.052 21.454.936
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3.821 1.511.053 -0,25 24,68 -94.302 37.292.788
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -40.455 1.514.874 -2,60 24,38 -986.293 36.932.628
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -25.779 5.852.765 -0,44 24,68 -636.226 144.446.240
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -272.923 5.878.544 -4,44 24,38 -6.653.863 143.318.903
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -5.580 903.527 -0,61 23,98 -133.808 21.666.577
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -11.736 909.107 -1,27 23,59 -276.852 21.445.834
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -9.603 1.555.329 -0,61 23,98 -230.280 37.296.789
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -20.205 1.564.932 -1,27 23,59 -476.636 36.916.746
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -64.783 6.151.467 -1,04 23,98 -1.553.496 147.512.179
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -136.312 6.216.250 -2,15 23,59 -3.215.600 146.641.338
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -13.738 920.843 -1,47 22,70 -311.853 20.903.136
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -23.648 1.585.137 -1,47 22,70 -536.810 35.982.610
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -159.542 6.352.562 -2,45 22,70 -3.621.603 144.203.157
2024-02-23 2024-02-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -119.360 6.512.104 -1,80 22,66 -2.704.698 147.564.277
2024-02-23 2024-02-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -35.164 6.631.464 -0,53 23,14 -813.695 153.452.077
2024-02-23 2024-02-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -149.337 6.666.628 -2,19 22,44 -3.351.122 149.599.132
2024-02-20 2024-02-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3.510 6.815.965 -0,05 23,40 -82.134 159.493.581
2024-02-20 2024-02-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -166.029 6.819.475 -2,38 22,71 -3.770.519 154.870.277
2024-02-20 2024-02-16 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -162.707 6.985.504 -2,28 23,14 -3.765.040 161.644.563
2024-02-20 2024-02-15 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.113 7.148.211 -0,03 24,45 -51.663 174.773.759
2024-02-20 2024-02-15 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -175.793 7.150.324 -2,40 23,88 -4.197.937 170.749.737
2022-12-14 2022-12-12 4 DYN Dyne Therapeutics, Inc.
Common Stock
P - Purchase 934.581 934.581 10,70 10.000.017 10.000.017
2022-04-05 2022-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16.500 16.500
2021-10-06 2021-10-04 4 GMTX Gemini Therapeutics, Inc. /DE
Stock Option (Right to Buy)
A - Award 17.245 17.245
2021-09-29 2021-09-29 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -30 608 -4,70 24,59 -738 14.951
2021-09-29 2021-09-29 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -16.556 0 -100,00 24,59 -407.112
2021-09-29 2021-09-28 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -24 638 -3,63 25,24 -606 16.103
2021-09-29 2021-09-28 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -13.089 16.556 -44,15 25,24 -330.366 417.873
2021-09-29 2021-09-27 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -95 662 -12,55 25,70 -2.442 17.013
2021-09-29 2021-09-27 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -51.294 29.645 -63,37 25,70 -1.318.256 761.876
2021-09-24 2021-09-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -54 757 -6,66 25,84 -1.395 19.560
2021-09-24 2021-09-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -28.862 80.939 -26,29 25,84 -745.765 2.091.383
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -140 811 -14,72 26,13 -3.659 21.194
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -1 109.801 0,00 26,55 -27 2.915.217
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -75.324 109.802 -40,69 26,13 -1.968.442 2.869.456
2021-09-24 2021-09-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -57 951 -5,65 25,89 -1.476 24.622
2021-09-24 2021-09-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -30.560 185.126 -14,17 25,89 -791.229 4.793.097
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -8 608 -1,30 26,39 -211 16.045
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -50 616 -7,51 25,77 -1.288 15.874
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -4.092 0 -100,00 26,39 -107.988
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -26.858 4.092 -86,78 25,77 -692.131 105.451
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -53 666 -7,37 25,69 -1.362 17.110
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -63 719 -8,06 25,08 -1.580 18.033
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -28.331 30.950 -47,79 25,69 -727.823 795.106
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -34.162 59.281 -36,56 25,08 -856.783 1.486.767
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -47 782 -5,67 25,20 -1.184 19.706
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -61 829 -6,85 24,76 -1.510 20.526
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -25.208 93.443 -21,25 25,20 -635.242 2.354.764
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -33.261 118.651 -21,89 24,76 -823.542 2.937.799
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -7 890 -0,78 25,12 -176 22.357
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -111 897 -11,01 24,82 -2.755 22.264
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -3.796 151.912 -2,44 25,12 -95.356 3.816.029
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -59.978 155.708 -27,81 24,82 -1.488.654 3.864.673
2021-06-11 2021-06-09 4 GBIO Generation Bio Co.
Stock Option (right to buy)
A - Award 15.000 15.000
2021-05-27 2021-05-26 4 DYN Dyne Therapeutics, Inc.
Stock Option (right to buy)
A - Award 19.596 19.596
2021-04-14 2021-04-14 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -12.874 0 -100,00 26,78 -344.766
2021-04-14 2021-04-14 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -10.539 12.874 -45,01 26,40 -278.230 339.874
2021-04-14 2021-04-13 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -7.354 23.413 -23,90 25,53 -187.748 597.734
2021-04-14 2021-04-13 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -35.791 30.767 -53,77 25,09 -897.996 771.944
2021-04-14 2021-04-12 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -10.771 66.558 -13,93 26,61 -286.616 1.771.108
2021-04-14 2021-04-12 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -63.353 77.329 -45,03 26,07 -1.651.613 2.015.967
2021-04-09 2021-04-09 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -2.132 140.682 -1,49 28,35 -60.442 3.988.335
2021-04-09 2021-04-09 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -41.549 142.814 -22,54 27,57 -1.145.506 3.937.382
2021-04-09 2021-04-08 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -3.191 184.363 -1,70 28,90 -92.220 5.328.091
2021-04-09 2021-04-08 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -40.359 187.554 -17,71 28,47 -1.149.021 5.339.662
2021-04-09 2021-04-07 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -1.894 227.913 -0,82 29,19 -55.286 6.652.780
2021-04-09 2021-04-07 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -37.970 229.807 -14,18 28,48 -1.081.386 6.544.903
2021-04-05 2021-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16.500 16.500
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
4.015.045
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
729.320
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
510.000
2021-01-28 2021-01-26 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -5.558 946.000 -0,58 46,14 -256.446 43.648.440
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -265 19.285 -1,36 41,95 -11.117 809.006
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.042 951.558 -0,11 41,95 -43.712 39.917.858
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -3.012 2.263.627 -0,13 41,95 -126.353 94.959.153
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -697 19.550 -3,44 42,00 -29.274 821.100
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.785 952.600 -0,29 42,00 -116.970 40.009.200
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.053 2.266.639 -0,35 42,00 -338.226 95.198.838
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -766 20.247 -3,65 42,13 -32.272 853.006
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -3.060 955.385 -0,32 42,13 -128.918 40.250.370
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.849 2.274.692 -0,39 42,13 -372.808 95.832.774
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6 21.013 -0,03 44,08 -264 926.253
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -30 21.019 -0,14 43,12 -1.294 906.339
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.432 21.049 -10,36 42,40 -103.117 892.478
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -24 958.445 0,00 44,08 -1.058 42.248.256
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -120 958.469 -0,01 43,12 -5.174 41.329.183
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -9.710 958.589 -1,00 42,40 -411.704 40.644.174
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -70 2.283.541 0,00 44,08 -3.086 100.658.487
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -349 2.283.611 -0,02 43,12 -15.049 98.469.306
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -28.078 2.283.960 -1,21 42,40 -1.190.507 96.839.904
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -181 23.481 -0,76 44,06 -7.975 1.034.573
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.855 23.662 -7,27 43,54 -80.767 1.030.243
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -240 25.517 -0,93 42,69 -10.246 1.089.321
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -722 968.299 -0,07 44,06 -31.811 42.663.254
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7.409 969.021 -0,76 43,54 -322.588 42.191.174
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -961 976.430 -0,10 42,69 -41.025 41.683.797
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.087 2.312.038 -0,09 44,06 -91.953 101.868.394
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -21.428 2.314.125 -0,92 43,54 -932.975 100.757.002
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.776 2.335.553 -0,12 42,69 -118.507 99.704.758
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -205 25.757 -0,79 43,92 -9.004 1.131.247
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.707 25.962 -6,17 43,32 -73.947 1.124.674
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -821 977.391 -0,08 43,92 -36.058 42.927.013
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6.817 978.212 -0,69 43,32 -295.312 42.376.144
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.374 2.338.329 -0,10 43,92 -104.266 102.699.410
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -19.712 2.340.703 -0,84 43,32 -853.924 101.399.254
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -230 27.669 -0,82 44,35 -10.200 1.227.120
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -750 27.899 -2,62 43,48 -32.610 1.213.049
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.099 28.649 -3,69 42,68 -46.905 1.222.739
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -917 985.029 -0,09 44,35 -40.669 43.686.036
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.996 985.946 -0,30 43,48 -130.266 42.868.932
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -4.389 988.942 -0,44 42,68 -187.323 42.208.045
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.653 2.360.415 -0,11 44,35 -117.661 104.684.405
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.666 2.363.068 -0,37 43,48 -376.798 102.746.197
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -12.691 2.371.734 -0,53 42,68 -541.652 101.225.607
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -151 29.748 -0,51 45,32 -6.843 1.348.179
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -635 29.899 -2,08 44,69 -28.378 1.336.186
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.549 30.534 -4,83 43,36 -67.165 1.323.954
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -151 32.083 -0,47 42,51 -6.419 1.363.848
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -100 993.331 -0,01 46,47 -4.647 46.160.092
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -604 993.431 -0,06 45,32 -27.373 45.022.293
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.535 994.035 -0,25 44,69 -113.289 44.423.424
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6.183 996.570 -0,62 43,36 -268.095 43.211.275
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -603 1.002.753 -0,06 42,51 -25.634 42.627.030
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.747 2.384.425 -0,07 45,32 -79.174 108.062.141
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7.330 2.386.172 -0,31 44,69 -327.578 106.638.027
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -17.883 2.393.502 -0,74 43,36 -775.407 103.782.247
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.745 2.411.385 -0,07 42,51 -74.180 102.507.976
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.869 32.234 -8,17 46,94 -134.671 1.513.064
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -606 35.103 -1,70 46,02 -27.888 1.615.440
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -45.027 1.003.356 -4,29 46,89 -2.111.316 47.047.363
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -19.620 1.048.383 -1,84 46,14 -905.267 48.372.392
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -33.133 2.413.130 -1,35 46,94 -1.555.263 113.272.322
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7.001 2.446.263 -0,29 46,02 -322.186 112.577.023
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -106 35.709 -0,30 46,91 -4.972 1.675.109
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.007 35.815 -5,31 45,97 -92.262 1.646.416
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -748 37.822 -1,94 45,46 -34.004 1.719.388
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.322 1.068.003 -0,22 46,93 -108.971 50.121.381
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -26.713 1.070.325 -2,44 46,06 -1.230.401 49.299.170
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.962 1.097.038 -0,27 45,45 -134.623 49.860.377
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.222 2.453.264 -0,05 46,91 -57.324 115.082.614
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -23.174 2.454.486 -0,94 45,97 -1.065.309 112.832.721
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.636 2.477.660 -0,35 45,46 -392.593 112.634.424
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -5.336.179 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -20.000.000 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 1.608.785 1.608.785
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 6.029.726 8.140.130 285,71
2020-09-16 3 DYN Dyne Therapeutics, Inc.
Common Stock
2.110.404
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Series C Preferred Stock
C - Conversion -2.683 0 -100,00
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Series A Preferred Stock
C - Conversion -15.051.020 0 -100,00
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Common Stock
C - Conversion 10.040.032 12.630.758 387,54
2020-06-15 2020-06-11 4 GBIO Generation Bio Co.
Stock Option (right to buy)
A - Award 52.000 52.000
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5.181.452
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5.181.452
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5.181.452
2020-04-02 2020-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16.500 16.500
2019-11-20 2019-11-18 4 REPL Replimune Group, Inc.
Common Stock
P - Purchase 1.100.000 1.100.000 13,61 14.971.000 14.971.000
2019-04-03 2019-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 13.500 13.500
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 13.500 13.500
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Series B Convertible Preferred Stock
C - Conversion -1.013.547 0 -100,00
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Series A Convertible Preferred Stock
C - Conversion -3.439.839 0 -100,00
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Common Stock
C - Conversion 1.013.547 4.453.386 29,46
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Common Stock
C - Conversion 3.439.839 3.439.839
2014-09-24 2014-09-22 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -44.000 149.459 -22,74
2014-09-24 2014-09-22 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 44.000 138.000 46,81 0,51 22.440 70.380
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -36.000 34.819 -50,83
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -6.000 188.833 -3,08
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -5.972 94.000 -5,97 33,89 -202.392 3.185.669
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -24.028 99.972 -19,38 33,37 -801.771 3.335.886
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 36.000 124.000 40,91 0,60 21.600 74.400
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 6.000 88.000 7,32 3,54 21.240 311.520
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -34.000 70.819 -32,44
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -8.000 194.833 -3,94
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -18.400 82.000 -18,33 30,05 -552.898 2.464.002
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -11.600 100.400 -10,36 29,26 -339.426 2.937.794
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 34.000 112.000 43,59 0,60 20.400 67.200
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 8.000 78.000 11,43 3,54 28.320 276.120
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -32.000 193.459 -14,19
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -4.000 104.819 -3,68
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -6.000 202.833 -2,87
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -6.446 70.000 -8,43 33,55 -216.258 2.348.444
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -23.554 76.446 -23,55 32,52 -765.903 2.485.787
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 32.000 100.000 47,06 0,51 16.320 51.000
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 4.000 68.000 6,25 0,60 2.400 40.800
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 6.000 64.000 10,34 3,54 21.240 226.560
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -27.000 225.459 -10,69
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -15.000 208.833 -6,70
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -1.264 58.000 -2,13 23,36 -29.529 1.354.967
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -28.736 59.264 -32,65 22,14 -636.341 1.312.366
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 27.000 88.000 44,26 0,51 13.770 44.880
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 15.000 61.000 32,61 3,54 53.100 215.940
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -5.000 252.459 -1,94
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -37.000 223.833 -14,19
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -30.000 46.000 -39,47 21,53 -645.840 990.288
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 5.000 76.000 7,04 0,51 2.550 38.760
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 37.000 71.000 108,82 3,54 130.980 251.340
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -35.000 257.459 -11,97
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -25.000 34.000 -42,37 20,05 -501.190 681.618
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 35.000 59.000 145,83 0,51 17.850 30.090
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -20.000 292.459 -6,40
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -50.000 260.833 -16,09
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale -50.000 24.000 -67,57 29,25 -1.462.500 702.000
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 20.000 74.000 37,04 0,51 10.200 37.740
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 50.000 54.000 1.250,00 3,54 177.000 191.160
2014-01-30 2014-01-28 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 27.406 27.406
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -14.000 312.459 -4,29
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -10.000 4.000 -71,43 20,19 -201.874 80.750
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 14.000 14.000 0,51 7.140 7.140
2013-07-03 2013-07-01 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 50.000 50.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)